Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Michael_Gilman
|
| gptkbp:collaboratedWith |
gptkb:Roche
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developedBy |
small molecule drugs targeting RNA
|
| gptkbp:focusesOn |
RNA-targeted small molecule medicines
|
| gptkbp:foundedYear |
2015
|
| gptkbp:founder |
gptkb:Michael_Gilman
|
| gptkbp:fundedBy |
gptkb:Pfizer_Ventures
gptkb:Celgene_Corporation gptkb:Canaan_Partners gptkb:Advent_Life_Sciences |
| gptkbp:headquartersLocation |
gptkb:Waltham,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Arrakis Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableEmployee |
Jennifer Petter
Russell Petter |
| gptkbp:openToPublic |
private
|
| gptkbp:website |
https://arrakistx.com/
|
| gptkbp:bfsParent |
gptkb:Versant_Ventures
|
| gptkbp:bfsLayer |
7
|